Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A24899 | 22381945 | Phytomedicine | Prevention of free fatty acid-induced lipid accumulation, oxidative stress, and cell death in primary hepatocyte cultures by a Gynostemma pentaphyllum extract. | 2012 | Details |
A24900 | 22380754 | BMC Gastroenterol | Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. | 2012 | Details |
A24901 | 22378327 | J Nutr | Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats. | 2012 | Details |
A24902 | 22378061 | Hepatology | Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. | 2012 | Details |
A24903 | 22375551 | J Biomed Sci | Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress. | 2012 | Details |
A24904 | 22375522 | Expert Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease and bariatric surgery. | 2012 | Details |
A24905 | 22374723 | Histol Histopathol | Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients. | 2012 | Details |
A24906 | 22374640 | Diabetes Care | Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). | 2012 | Details |
A24907 | 22373863 | Dig Dis Sci | The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease. | 2012 | Details |
A24908 | 22373558 | Ned Tijdschr Geneeskd | [Consequences of non-alcoholic fatty liver disease still unclear]. | 2012 | Details |
A24909 | 22372668 | Histopathology | Quantifying hepatic steatosis - more than meets the eye. | 2012 | Details |
A24910 | 22372457 | Histopathology | The epidemiology, pathogenesis and histopathology of fatty liver disease. | 2012 | Details |
A24911 | 22371632 | World J Gastroenterol | Role of cytokines and chemokines in non-alcoholic fatty liver disease. | 2012 | Details |
A24913 | 22367065 | Dig Dis Sci | Innate immune reactivity of the ileum-liver axis in nonalcoholic steatohepatitis. | 2012 | Details |
A24914 | 22364559 | J Proteome Res | Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. | 2012 | Details |
A24915 | 22364184 | J Agric Food Chem | Synergistic effect of cyanidin and PPAR agonist against nonalcoholic steatohepatitis-mediated oxidative stress-induced cytotoxicity through MAPK and Nrf2 transduction pathways. | 2012 | Details |
A24916 | 22364002 | Eksp Klin Gastroenterol | [Study of clinical efficiency of essential phospholipids and silymarin combination in nonalcoholic and alcoholic steatohepatitis]. | 2011 | Details |
A24917 | 22363403 | PLoS One | A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease. | 2012 | Details |
A24918 | 22362903 | Postgrad Med J | Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma). | 2012 | Details |
A24919 | 22360487 | Curr Med Chem | Non-alcoholic steatohepatitis: what can we learn from animal models? | 2012 | Details |
A24921 | 22359630 | PLoS One | Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24922 | 22359625 | PLoS One | Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. | 2012 | Details |
A24923 | 22356310 | J Dig Dis | Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study. | 2012 | Details |
A24924 | 22351677 | In Vivo | Detecting plasma cell precursors in autoimmune hepatitis. | 2012 | Details |
A24925 | 22350157 | Mol Biol Rep | A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease. | 2012 | Details |
A24927 | 22348916 | Drugs Today (Barc) | Current therapies for nonalcoholic fatty liver disease. | 2011 | Details |
A24928 | 22348670 | Ugeskr Laeger | [Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis]. | 2012 | Details |
A24929 | 22345340 | Ann Hepatol | Evidence for liver injury in the setting of obstructive sleep apnea. | 2012 | Details |
A24930 | 22345333 | Ann Hepatol | Transient elastography in non-alcoholic fatty liver disease. | 2012 | Details |
A24931 | 22343784 | Eur J Gastroenterol Hepatol | Calorie and alcohol consumption in nonalcoholic fatty liver disease. | 2012 | Details |
A24932 | 22343513 | Clin Gastroenterol Hepatol | Association between puberty and features of nonalcoholic fatty liver disease. | 2012 | Details |
A24933 | 22343419 | Free Radic Biol Med | Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. | 2012 | Details |
A24935 | 22341049 | Ultrasound Med Biol | Liver elasticity in NASH patients evaluated with real-time elastography (RTE). | 2012 | Details |
A24936 | 22340817 | BMC Gastroenterol | Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. | 2012 | Details |
A24937 | 22340678 | Liver Int | Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects. | 2012 | Details |
A24938 | 22340564 | Chin Med J (Engl) | Intestinal immune barrier integrity in rats with nonalcoholic hepatic steatosis and steatohepatitis. | 2012 | Details |
A24939 | 22338037 | Am J Clin Nutr | Choline intake in a large cohort of patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24940 | 22334337 | Hepatology | Specific immunization strategies against oxidized low-density lipoprotein: a novel way to reduce nonalcoholic steatohepatitis in mice. | 2012 | Details |
A24941 | 22333691 | Hum Immunol | High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation. | 2012 | Details |
A24942 | 22331365 | J Gastroenterol | Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study. | 2012 | Details |
A24943 | 22330232 | Clin Gastroenterol Hepatol | Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis. | 2012 | Details |
A24944 | 22320918 | J Gastroenterol Hepatol | Pathophysiology guided treatment of nonalcoholic steatohepatitis. | 2012 | Details |
A24945 | 22320917 | J Gastroenterol Hepatol | Regulation of transglutaminase-mediated hepatic cell death in alcoholic steatohepatitis and non-alcoholic steatohepatitis. | 2012 | Details |
A24946 | 22320915 | J Gastroenterol Hepatol | Iron and steatohepatitis. | 2012 | Details |
A24947 | 22328022 | J Gastroenterol | Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. | 2012 | Details |
A24948 | 22327056 | Obesity (Silver Spring) | Lipoic acid improves mitochondrial function in nonalcoholic steatosis through the stimulation of sirtuin 1 and sirtuin 3. | 2012 | Details |
A24949 | 22326764 | Clin Res Hepatol Gastroenterol | HCC and NASH: how strong is the clinical demonstration? | 2012 | Details |
A24950 | 22326465 | J Hepatol | Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. | 2012 | Details |
A24951 | 22326434 | Gastroenterology | Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. | 2012 | Details |
A24952 | 22319959 | Acta Gastroenterol Belg | Risk factors for non-alcoholic fatty liver disease in a Chinese population. | 2011 | Details |
A24953 | 22319522 | Exp Diabetes Res | Pentoxifylline attenuates methionine- and choline-deficient-diet-induced steatohepatitis by suppressing TNF-α expression and endoplasmic reticulum stress. | 2012 | Details |
A24954 | 22315014 | Endocrine | The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy. | 2012 | Details |
A24955 | 22314430 | J Hepatol | IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease. | 2012 | Details |
A24956 | 22314419 | J Hepatol | Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers. | 2012 | Details |
A24957 | 22313887 | Zhong Xi Yi Jie He Xue Bao | [Effects of the mixture of Swertia pseudochinensis Hara and Silybum marianum Gaertn extracts on CCl(4)-induced liver injury in rats with non-alcoholic fatty liver disease]. | 2012 | Details |
A24958 | 22312449 | World J Hepatol | Overview of screening methods for fatty liver disease in children. | 2012 | Details |
A24959 | 22311412 | Chin J Integr Med | Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease. | 2012 | Details |
A24960 | 22310735 | J Gastroenterol | Inflammation and fibrogenesis in steatohepatitis. | 2012 | Details |
A24961 | 22308841 | J Pediatr Endocrinol Metab | The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children. | 2011 | Details |
A24962 | 22308697 | Zhongguo Zhong Yao Za Zhi | [Research on therapeutic effect and hemorrheology change of berberine in new diagnosed patients with type 2 diabetes combining nonalcoholic fatty liver disease]. | 2011 | Details |
A24963 | 22308054 | Phytother Res | The efficacy of licorice root extract in decreasing transaminase activities in non-alcoholic fatty liver disease: a randomized controlled clinical trial. | 2012 | Details |
A24964 | 22307032 | Gastroenterology | Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. | 2012 | Details |
A24966 | 22300605 | Endocrinol Nutr | The role of gut hormones in controlling the food intake: what is their role in emerging diseases? | 2012 | Details |
A24967 | 22299674 | Liver Int | The Framingham risk score and heart disease in nonalcoholic fatty liver disease. | 2012 | Details |
A24968 | 22297845 | Nature | Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. | 2012 | Details |
A24969 | 22297300 | Am J Physiol Endocrinol Metab | Adiponectin promoter activator NP-1 reduces body weight and hepatic steatosis in high-fat diet-fed animals. | 2012 | Details |
A24970 | 22295101 | PLoS One | LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease. | 2012 | Details |
A24971 | 22294826 | World J Gastroenterol | Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. | 2012 | Details |
A24972 | 22294100 | Cell Mol Life Sci | A role for sphingolipids in the pathophysiology of obesity-induced inflammation. | 2012 | Details |
A24973 | 22291824 | Arch Med Sci | Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. | 2011 | Details |
A24974 | 22291803 | Arch Med Sci | Prevalence of non-alcoholic fatty liver disease and its relation to hypoadiponectinaemia in the middle-aged and elderly Chinese population. | 2011 | Details |
A24975 | 22290395 | Hepatology | Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. | 2012 | Details |
A24976 | 22288305 | Eur Rev Med Pharmacol Sci | The psoriatic patient profile for infliximab. | 2011 | Details |
A24978 | 25586046 | Clin Obes | Liver fat content investigated by magnetic resonance spectroscopy in obese children and youths included in multidisciplinary treatment. | 2012 | Details |
A24979 | 22285877 | Magn Reson Imaging | Cross-sectional investigation of correlation between hepatic steatosis and IVIM perfusion on MR imaging. | 2012 | Details |
A24981 | 22282244 | J Huazhong Univ Sci Technolog Med Sci | Relationship between serum TSH level with obesity and NAFLD in euthyroid subjects. | 2012 | Details |
A24982 | 22280920 | Physiol Behav | Non-alcoholic fatty liver disease impairs hippocampal-dependent memory in male rats. | 2012 | Details |
A24983 | 22280100 | Expert Opin Drug Metab Toxicol | Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions. | 2012 | Details |
A24984 | 22278337 | Diabetologia | Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. | 2012 | Details |
A24985 | 22278114 | Panminerva Med | A 2012 clinical update for internists in adult nonalcoholic fatty liver disease. | 2012 | Details |
A24986 | 22278044 | Eur J Nutr | Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model. | 2012 | Details |
A24987 | 22275361 | J Biol Chem | Hepatocyte-specific deletion of Janus kinase 2 (JAK2) protects against diet-induced steatohepatitis and glucose intolerance. | 2012 | Details |
A24988 | 22274553 | Acta Diabetol | Factors that influence basal insulin requirement in type 2 diabetes. | 2012 | Details |
A24989 | 22273644 | Saudi Med J | Serum thrombopoietin levels in patients with non-alcoholic fatty liver disease. | 2012 | Details |
A24991 | 22271511 | Hepatology | Nonalcoholic fatty liver disease is associated with coronary artery calcification. | 2012 | Details |
A24992 | 22271167 | Hepatology | Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice. | 2012 | Details |
A24993 | 22270437 | Obstet Gynecol | Spleno-parametrial ectopic varices: an unusual porto-systemic shunt in portal hypertension. | 2012 | Details |
A24994 | 22269154 | Gene | Association of adiponectin gene functional polymorphisms (-11377C/G and +45T/G) with nonalcoholic fatty liver disease. | 2011 | Details |
A24995 | 22268100 | Am J Physiol Gastrointest Liver Physiol | Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids. | 2012 | Details |
A24996 | 22268099 | Am J Physiol Gastrointest Liver Physiol | Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice. | 2012 | Details |
A24997 | 22265683 | Dig Liver Dis | Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property. | 2012 | Details |
A24999 | 22259190 | J Nutr | Apo-10'-lycopenoic acid, a lycopene metabolite, increases sirtuin 1 mRNA and protein levels and decreases hepatic fat accumulation in ob/ob mice. | 2012 | Details |
A25000 | 22258181 | Hum Genet | A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease. | 2012 | Details |
A25001 | 22257474 | J Dig Dis | Liver X receptors bridge hepatic lipid metabolism and inflammation. | 2012 | Details |
A25002 | 22257210 | Nucleosides Nucleotides Nucleic Acids | A tetra-primer amplification refractory mutation system-polymerase chain reaction for the detection of rs8099917 IL28B genotype. | 2012 | Details |
A25003 | 22254139 | Radiol Res Pract | The severity of Fatty liver disease relating to metabolic abnormalities independently predicts coronary calcification. | 2011 | Details |
A25004 | 22253482 | Gut | Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice. | 2012 | Details |
A25005 | 22251466 | Hepatobiliary Pancreat Dis Int | Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. | 2012 | Details |
A25006 | 22251279 | Hepatol Res | Usefulness of Technetium-99 m-2-methoxy-isobutyl-isonitrile liver scintigraphy for evaluating disease activity of non-alcoholic fatty liver disease. | 2012 | Details |
A25007 | 22249728 | Nat Rev Gastroenterol Hepatol | Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. | 2012 | Details |